Beyond Testosterone
Webinar

A cross-sectional customer survey of 146 consistent users - 79.5% with regular or severe baseline gut and IBS (irritable bowel syndrome) symptoms – assessed effectiveness, symptom-level relief among prior sufferers, and outcomes by duration of use.

The results?

Among definitively rated users, 95.0% found Gut Works® effective (46.8% extremely effective). A clear duration-response emerged: extremely-effective ratings rose from 30.8% at under two months to 58.8% at four months or more, with combined-positive reaching 97.6%. Symptom relief among prior sufferers reached 66.1% (diarrhoea), 62.9% (bloating) and 60.5% (wind) - the most common symptoms of IBS. 90% would recommend Gut Works®.

Duration-dependent efficacy

Extremely-effective ratings rose from 30.8% to 58.8% across duration bands.

Consistent with the biology of microbiome establishment over sustained supplementation.

Relief concentrated in prior sufferers

62.9% bloating, 66.1% diarrhoea, 60.5% wind - among those affected at baseline.

Calculated only among users who reported each symptom before use.

Strong real-world advocacy

90% would recommend it; mean recommendation 8.7 out of 10.

From a highly adherent cohort (96.6% daily or most days).

A cross-sectional survey of 61 customers - 93.4% aged 45+, 45.9% with a musculoskeletal diagnosis - assessed effectiveness, symptom relief among prior sufferers, and outcomes by duration.

The results?

94.5% of rated users found it effective (40.0% very effective). Among prior sufferers, 81.6% reported relief from joint aches and 69.2% from inflammation, concentrated anatomically in the knees, hips and hands. The very-effective rating rose to 50.0% at two years or more. 85% would recommend it.

Mechanistically coherent relief

81.6% joint-pain and 69.2% inflammation relief.

A pattern consistent with curcumin's established anti-inflammatory action.

Cumulative duration-response

Very-effective ratings reached 50.0% at two years or more.

Supporting sustained supplementation for maximal benefit.

High advocacy

85% would recommend it; mean recommendation 8.6 out of 10.

84.5% scored 7 or above.

Of 335 customers who had tried Debloat & Detox, effectiveness, time to relief and symptom-level outcomes were assessed (285 gave a definitive rating).

The results?

Among definitively rated users, 80.7% found it effective. Relief was concentrated in the product's target symptoms - bloating (68.8%) and wind (28.7%). Over half (53.5%) of responders noted relief within two weeks.

Symptom-targeted profile

68.8% bloating and 28.7% wind relief.

A concentrated profile suited to bloating-dominant presentations.

Positioned alongside Gut Works®

80.7% positive versus 83.0% for Gut Works®.

Gut Works® suits broader multi-symptom cases; Debloat & Detox® is bloating-focused.

Rapid onset in responders

53.5% within two weeks; 73.5% within three.

For those who respond, relief tends to come early.

Individual-level cross-tabulation of 978 MenoFriend® users (735 established, 2+ months), with HRT (n=574) as a same-population comparator.

The results?

82.6% of all users and 88.7% of established users rated MenoFriend® effective, versus 68.5% for HRT, with a far lower dissatisfaction rate (17.4% vs 31.5%). A clear duration-response was seen (64.2% at under two months rising to 95.8% at 1-2 years). MenoFriend® outperformed HRT specifically for brain fog (35.0% vs 26.8%).

Favourable vs HRT in this population

88.7% (established) vs 68.5% for HRT; nearly half the dissatisfaction rate.

Note: ~25% of users also used HRT concurrently.

Clear duration-response

Combined-positive rose from 64.2% to 95.8% across duration bands.

Adequate exposure (3+ months) is key to assessing benefit.

Distinct cognitive edge

Brain-fog relief 35.0% vs 26.8% for HRT.

Alongside hot flushes/night sweats (44.8%) and mood (42.4%).

Within a 265-woman survey, PMS Hero® users were assessed for effectiveness and symptom-level relief, mapped against symptom prevalence and disruptiveness.

The results?

90.9% of rated users found PMS Hero® effective (51.5% extremely or very effective). Mood swings - the most prevalent (70.5%) and most disruptive (39.6%) PMS symptom - were relieved in 72.7% of users. Relief spanned all five of the most-disruptive symptoms. PMS Hero® outperformed every self-management strategy assessed.

Targets the lead symptom

72.7% mood-swing relief.

Directly addressing PMS's most prevalent and most disruptive symptom.

Across the disruptive cluster

Relief reported across mood, low mood, sleep, bloating and headaches.

Coverage of all five top-rated disruptors.

Outperforms standard strategies

90.9% positive vs sub-7/10 means for all common remedies.

Including ibuprofen, general supplements, exercise and paracetamol.

Of 1,202 women surveyed, pH Hero® users were assessed for effectiveness, time to relief and symptom-level outcomes, benchmarked against creams/pessaries, supplements and cranberry juice.

The results?

78.7% of rated users found pH Hero® effective; its 38.7% extremely-effective rating was the highest top-box score of any remedy - ahead of creams and pessaries (33.8%) and far ahead of cranberry juice (7.4%). Relief spanned dryness, discomfort and itchiness alongside thrush, UTIs, BV and pH balance; 75% of responders noted benefit within four weeks.

Highest top-box of any option

38.7% extremely effective - above creams/pessaries (33.8%).

And well above probiotics (16.2%) and cranberry juice (7.4%).

Acts on an upstream mechanism

26.4% reported improved overall pH balance.

A common upstream factor across UTIs, BV and thrush.

Spans chronic and recurrent

Dryness 31.9%, itchiness/discomfort 33.3%, thrush 26.4%, UTIs 25.0%.

Covering both daily-living symptoms and recurrent infection.

A cross-sectional customer survey of 352 highly adherent users (99.7% daily or most days) assessed effectiveness, a duration-stratified analysis, symptom-level relief, time to benefit and a comparison by HRT status.

The results?

94.6% rated PeriMenoFriend® effective (44.3% extremely effective; combined negative just 5.4%). A clear duration-response emerged — extremely-effective ratings rose from 40.2% at under two months to 59.5% at four months or more, with combined-positive reaching 100% in the longest band. 88.9% reported relief in at least one symptom (mean 3.2), most often anxiety/mood swings (55.7%), hot flushes/night sweats (41.8%) and brain fog (39.2%). Among HRT-naïve users, 97.6% found it effective, and onset was rapid (75.8% within four weeks).

Duration-dependent efficacy

Extremely-effective ratings rose from 40.2% to 59.5% across duration bands.

Combined-positive reached 100% beyond four months, supporting sustained daily use.

Broad psychological and vasomotor relief

Anxiety/mood swings 55.7%, hot flushes/night sweats 41.8%, brain fog 39.2%.

Mean 3.2 symptoms relieved per user; 62.5% across three or more.

Strong non-hormonal signal

97.6% effective among the 70.2% who had never taken HRT.

Supporting its role where HRT is unsuitable or unwanted.

We surveyed 343 women, most in midlife, on their awareness of and concern about bone health, the protective steps they take, their recognition of the gut–bone link, and the symptoms they already have.

What we found:

88.2% were aware of the postmenopausal risk to bone health and 77.2% were concerned - yet 42% rarely or never do weight-bearing or resistance exercise, the most protective behaviour, and this held even among those who were aware or concerned. Musculoskeletal symptoms were already common (78.7%, led by joint pain at 66.5%), the gut–bone link was under-recognised (43.3% didn't make the connection); and despite high concern, 41.1% were taking nothing for their bones, while 67.9% wanted a new solution.

Awareness isn't translating into action

42% rarely or never do the exercise that protects bone density.

The gap holds even among women who are aware of the risk and concerned about it.

The gut–bone link is missed

43.3% don't recognise gut health as important for their bones.

Despite the gut's role in absorbing bone-critical nutrients like calcium and vitamin D.

A clear unmet need

41.1% take nothing for their bones, yet 67.9% want a new solution.

High concern with low action points to real demand for accessible, evidence-based support.

Within a survey of 651 adults, we compared 138 DRV+ Daily Multivitamin users against users of every other multivitamin brand.

The results?

98.5% rated the DRV+ Daily Multivitamin positive for overall wellbeing. It outperformed the market average in all twelve health areas measured - with the biggest leads in brain fog, concentration, mood and skin - and 88.8% considered it value for money.

Ahead of the market

99% positive for wellbeing, versus 94% across all brands.

With a higher 'highly effective' rate than the all-brand average.

Strongest where it counts

Biggest leads in brain fog, concentration, mood and skin.

Outperforming the average across all twelve health areas measured.

Trusted value

88.8% rated it value for money; 75.2% felt protected on off-diet days.

Both higher than the all-brand figures.

We surveyed 651 adults on multivitamin motivations, behaviours, ingredient awareness and perceived effectiveness across twelve health areas.

What we found:

94.4% of daily users rated their multivitamin positive overall, and 70% noticed benefit within four weeks. Immunity (70%), energy (57%) and skin (52%) performed best; sleep and anxiety were weakest - the biggest unmet needs. Over 40% had never checked for unnecessary additives because they didn't know what to look for.

High satisfaction, uneven domains

Strongest for immunity, energy and skin; weakest for sleep and anxiety.

Marking the clearest gaps in current formulations.

An education gap

40%+ don't know how to check for unnecessary additives.

A meaningful consumer-awareness opportunity.

What drives switching

Lack of efficacy, cost and additives are the top reasons people leave a brand.

The priorities that determine long-term loyalty.

We surveyed 811 adults on the prevalence, breadth and psychosocial impact of gut symptoms, and the strategies they use to manage them.

What we found:

92% reported some degree of gut issues, carrying a mean of 6.2 symptoms each - led by bloating (81%), fatigue (62%) and wind (52%). 97% said gut health affected another area of wellbeing such as energy, weight or mood, and 67% found symptoms worsened with anxiety. No management strategy was rated 'very effective' by more than one in five users.

It's rarely just one symptom

Mean 6.2 symptoms per person; 41% had seven or more at once.

Gut issues cluster rather than appear in isolation.

It spills into everything

97% said gut health affects energy, weight or mood.

And 67% report a clear gut–anxiety link.

A real unmet need

No strategy was 'very effective' for more than 1 in 5.

Pointing to demand for genuinely effective options.

We surveyed 76 customers who had taken Hair Saviour® daily for two months or more - long enough to reflect the hair-growth cycle - tracking strength, growth, condition and thickness.

The results?

78.9% rated Hair Saviour® effective. 86.8% noticed improvement in at least one area - most often hair strength (68.4%) and condition (60.5%) - and 54.7% reported new hair growth. Notably, not one person who saw a physical hair improvement rated the product 'not at all effective'.

Strength and condition first

68.4% saw stronger hair and 60.5% better condition.

The two most consistently reported improvements across users.

New growth is achievable

54.7% reported new hair growth.

A meaningful result, since new growth is the slowest hair benefit to appear.

Consistency is everything

Most users saw results between 4 and 8 weeks - some longer.

Hair works to its own cycle, so daily use for at least 2-3 months gives it the best chance.

We surveyed 356 men across 16 health domains, measuring concern, help-seeking, prostate literacy and psychological burden.

What we found:

94.1% reported at least one active health concern, yet help-seeking never exceeded 34% in any domain. The gap was widest for sexual health: just 1.4% had consulted a professional about libido. Prostate literacy was low (51.7% didn't know how to support it), and screening was rarest in the youngest men (87% of 30-40s had never been checked).

Concern doesn't become care

94% concerned, yet under 34% seek any help in any domain.

Action lags furthest behind for stigmatised conditions.

The silent areas

Only 1.4% consulted anyone about libido, 3.7% about ED.

Despite meaningful levels of concern and worry.

Education aimed at the wrong age

87% of men aged 30–40 had never had a prostate check.

Screening is rarest where the modifiable-risk window is longest.

We surveyed 317 adults on the breadth of skin concerns, their psychosocial impact, and beliefs about diet and lifestyle.

What we found:

99.7% reported at least one skin concern, a mean of 3.6 each - led by wrinkles/fine lines (67.5%) and signs of ageing (61.8%). 62.1% said skin affects their confidence and 18% had skipped a social event because of it. 88% linked skin to stress and sleep, yet only 42% regularly drink two litres of water a day.

Rarely a single issue

Mean 3.6 concerns each; 69% had three or more.

Concerns typically present together.

More than skin-deep

62% said skin affects confidence; 18% skipped a social event.

A clear psychosocial dimension.

Belief outpaces behaviour

88% link skin to stress/sleep, but only 42% hydrate adequately.

A gap nutrition and education can address.

We surveyed 545 adults on sleep duration, the nature of their difficulties, daytime impact, and the sleep-stress relationship.

What we found:

77.4% averaged under seven hours a night and 47% under six. 85.7% reported an ongoing difficulty - most often waking through the night (60%) and not waking refreshed (53%). The daytime toll was led by low energy (67%). Sleep and stress were tightly linked: 75% said stress worsens sleep, and 43% said poor sleep itself causes anxiety.

Maintenance, not onset

Waking through the night (60%) and unrefreshing sleep (53%) lead.

The dominant problem is staying asleep, not falling asleep.

A heavy daytime cost

Low energy (67%) and poor concentration (57%) lead the fallout.

Alongside irritability and anxiety.

A self-reinforcing loop

75% say stress worsens sleep; 43% say poor sleep causes anxiety.

Compounded by diet - pointing to integrated support.

We surveyed 545 adults on stress prevalence and frequency, symptoms, functional impact, and coping strategies.

What we found:

55.8% described their stress as high or overwhelming and 51.9% felt anxious or stressed daily. Poor sleep was the leading symptom (69.2%). Stress reached behaviour and work - 67% ate less healthily and 54% avoided social situations - yet 71.9% felt employers don't do enough. Lifestyle strategies such as walking and exercise were both most used and most effective.

Frequent, not occasional

52% feel anxious or stressed every day.

Including 15% for most of the day, every day.

It changes behaviour

67% eat less healthily; 54% avoid social situations.

A self-reinforcing functional burden.

Lifestyle leads on what works

Exercise (97%) and walking outdoors (96%) rated most effective.

Outperforming alcohol and used more than medication.

We surveyed 1,202 women on the prevalence, recurrence and impact of vaginal health conditions, and how well current remedies perform.

What we found:

55.1% reported vaginal dryness or atrophy - half experiencing it daily or near-daily - and 32.6% had had at least one infection, mostly recurrent. 39.7% of sexually active women reported pain during sex, and 58% said their sex life was affected. Cranberry juice, the most popular remedy, was the least effective (59.3%).

Chronic for most sufferers

Half of those with dryness feel it daily or near-daily; infections recur.

These are ongoing, not one-off, conditions.

Menopause is the turning point

Dryness onset averaged 47.5 years; issues worsen with age for 49%.

The transition is the consistent inflection point.

Popular doesn't mean effective

Cranberry juice: most used, least effective (59.3%).

A clear gap for better-evidenced options.

We surveyed 1,030 adults on weight perception, the barriers they face, the role of menopause and sleep, and their attitudes to GLP-1 medication versus natural supplements.

What we found:

76.1% find weight hard to manage, despite 79.3% actively trying to manage their weight, and most exercising regularly. The menopausal transition was the single biggest factor, 68.8% of peri-, meno- and postmenopausal women found weight 'a lot harder' with age (versus 44.1% of other women), concentrated in the 40s and 50s and around the middle. Cravings, sweet tooth and emotional eating outranked cost and time in challenges to managing weight, and 60.1% would choose a natural, clinically proven supplement, though 60.8% didn't realise such options exist.

Menopause is the turning point

68.8% of menopausal women find weight management 'a lot harder' with age.

A near 25-point jump versus other women - peaking in the 40s and 50s.

It's about cravings, not willpower

64.7% cite cravings or emotional eating as their biggest barrier.

Appetite and emotion outrank practical barriers like cost and time.

Clear demand for natural support

60.1% would choose a natural supplement over GLP-1 medication.

Yet 60.8% don't realise effective options already exist.

We surveyed 1,526 women across the menopausal transition on gut symptoms, their timing, frequency and downstream impact.

What we found:

66.8% reported noticeably worse gut health since menopausal symptoms began - typically starting in peri-menopause (58%). Bloating led (73%), experienced daily or near-daily by 77% of those affected. 79% reported a psychosocial consequence. Among gut-targeted supplements assessed, Gut Works® rated strongest (78.4% positive).

It starts earlier than expected

58% first noticed gut changes in peri-menopause.

Often before menopause is formally established.

Persistent, not occasional

77% of bloating sufferers experience it daily or near-daily.

With a mean of 3.4 gut symptoms per woman affected.

Diet alone isn't enough

Only 11% found dietary change 'very effective'; Gut Works® led supplements at 78.4%.

Targeted support outperformed diet for most women

We surveyed 265 women on PMS symptom burden, its impact on daily life and work, and how well current coping strategies actually perform.

What we found:

95.4% reported regular PMS symptoms, a mean of 8.3 each, led by mood swings (70.5%) - also the most disruptive (39.6%). PMS affected relationships for 67.6% and caused 40.7% to take time off, yet 76.9% felt unsupported by employers or schools. No coping strategy averaged above 7/10.

Mood leads the burden

Mood swings: most prevalent (70.5%) and most disruptive (39.6%).

Psychological symptoms dominate the experience of PMS.

It reaches work and relationships

40.7% took time off; 67.6% saw relationships affected.

Yet 76.9% felt institutionally unsupported.

Current remedies fall short

No coping strategy averaged above 7/10.

A clear gap for effective, evidence-based support.

We surveyed 50 verified Women's ProMulti users, tracking effectiveness, the benefits they noticed, and how it compared to products they had used before.

The results?

92.3% rated Women's ProMulti effective, and not one person rated it 'not at all effective'. Among those who had tried other multivitamins or greens, 89.7% judged it better - 53.8% 'a lot better'. Several users reported mood and sleep benefits they hadn't even set out to address. 82% of users would recommend it.

Better than your last multi

89.7% rated it better than other multivitamins or greens.

Over half said 'a lot better' - and none rated it worse.

Unexpected extras

More users felt mood and sleep benefits than originally went looking for them.

Broader-spectrum support than many expect from a daily multi.

Trusted by the people who use it

82% would recommend it, with a mean score of 8.2 out of 10.

Strong advocacy from a committed, mostly midlife user base.